✦ LIBER ✦

Efficient inhibition of B-cell lymphoma xenografts with a novel recombinant fusion protein: anti-CD20Fab-LDM

✍ Scribed by Xin, C; Ye, S; Ming, Y; Shenghua, Z; Qingfang, M; Hongxing, G; Xu, S; Yuanfu, X; Yuan, Z; Dongmei, F

Book ID: 109855478
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 646 KB
Volume: 17
Category: Article
ISSN: 0969-7128
DOI: 10.1038/gt.2010.76

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficient inhibition of human B-cell lym

Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20×anti-CD3 bispecific diabody

✍ Dongsheng Xiong; Yuanfu Xu; Hanzhi Liu; Hui Peng; Xiaofeng Shao; Zenzu Lai; Dong 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Bi20 (fBTA05), a novel trifunctional bis

Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti-CD20 × anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels

✍ Michael Stanglmaier; Margot Faltin; Peter Ruf; Annette Bodenhausen; Petra Schröd 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 312 KB

## Abstract Trifunctional bispecific antibodies can efficiently mediate tumor cell killing by redirecting T cells and immune accessory cells to the tumor cell. Here, we describe the new trifunctional antibody, Bi20 (FBTA05, anti‐CD20 × anti‐CD3), that connects B cells and T cells __via__ its variab